Adma Biologics (ADMA) | Stock Overview & Key Data

Adma Biologics Inc. | Mid-cap | Healthcare

$18.21

0.28%

| Adma Biologics Stock Comparison:

Adma Biologics vs Vertex Adma Biologics vs Regeneron Adma Biologics vs Blueprint Medicines Adma Biologics vs Roivant Sciences Adma Biologics vs Bio-Techne Adma Biologics vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Adma Biologics Performance Comparison

Loading chart data...

Adma Biologics

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $17.88 High: $18.92

on June 30, 2025

52 Week Range

Low: $10.21 High: $25.67

on August 5, 2024

on April 28, 2025

All-Time High: $25.67 on April 28, 2025

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $4.3B

EPS i 0.84

P/E Ratio (TTM) i 21.27

Forward P/E i 24.82

P/B Ratio i 11.42

PEG Ratio i 24.82

Div. Yield i N/A

ROE i 78.45%

Beta i 0.473

Debt to Equity i 21.96

Financial Highlights

Profitability

Gross Margin i 53.22%

Operating Margin i 30.38%

Profit Margin i 45.01%

Returns and Earnings

Return on Assets (TTM) i 22.06%

Return on Equity (TTM) i 78.45%

EBITDA i $160.8M

Net Income (TTM) i $206.8M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Adma Biologics ADMA	4.27B Mid-cap	1.90%	-8.22%	-8.22%	4.12%	1.34%	58.90%	688.31%	543.46%
Vertex VRTX	114.06B Large-cap	0.37%	0.71%	-8.17%	11.48%	9.72%	-5.40%	54.32%	52.32%
Regeneron REGN	55.27B Large-cap	2.56%	7.08%	-17.22%	-25.28%	-26.59%	-49.24%	-15.54%	-15.44%
Blueprint Medicines BPMC	8.29B Mid-cap	-0.17%	26.47%	44.82%	47.64%	47.00%	14.75%	126.55%	62.31%
Roivant Sciences ROIV	7.82B Mid-cap	-2.00%	2.55%	11.69%	-1.40%	-6.71%	5.82%	132.85%	13.61%
Bio-Techne TECH	7.92B Mid-cap	4.36%	6.30%	-12.25%	-28.83%	-28.02%	-26.31%	-40.20%	-21.53%

Ownership & Short Interest

Insider Ownership i 2.59%

Institutional Ownership i 88.42%

Shares Short i 14M

Short Ratio i 4.25

Short % of Shares Outstanding i 7.36%

Average 10-Day Volume i 4M

Average 90-Day Volume i 3M

Adma Biologics Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Adma Biologics would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is ADMA's 52-week high and low?

In the last 52 weeks, Adma Biologics reached a high of $25.67 (on April 28, 2025) and a low of $10.21 (on August 5, 2024).

What is the market cap and P/E ratio for ADMA?

Curious about Adma Biologics's size and valuation? Its market capitalization stands at 4.27B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.27, and the forward P/E (looking ahead) is 24.82.

Does ADMA pay dividends? If so, what's the yield?

As for dividends, Adma Biologics isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Adma Biologics's main competitors or similar companies to consider before investing?

When looking at Adma Biologics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	114.06B	Healthcare	Biotechnology	-5.40%	54.32%
Regeneron REGN	55.27B	Healthcare	Biotechnology	-49.24%	-15.54%
Blueprint Medicines BPMC	8.29B	Healthcare	Biotechnology	14.75%	126.55%
Roivant Sciences ROIV	7.82B	Healthcare	Biotechnology	5.82%	132.85%
Bio-Techne TECH	7.92B	Healthcare	Biotechnology	-26.31%	-40.20%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Adma Biologics Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Adma Biologics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 78.45%, the Debt to Equity ratio from the most recent quarter is 21.96, and its Gross Profit Margin stands at 53.22%.

What is the recent revenue and earnings growth for ADMA?

Looking at Adma Biologics's growth, its revenue over the trailing twelve months (TTM) was $459M. Compared to the same quarter last year (YoY), quarterly revenue grew by 40.20%, and quarterly earnings saw a YoY growth of 51.10%.

How much of ADMA stock is held by insiders and institutions?

Wondering who owns Adma Biologics stock? Company insiders (like executives and directors) hold about 2.59% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 88.42%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.